Loading...

Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer

BACKGROUND: Chemoresistance is one of the main problems in treatment of cancer. Periostin (PN) is a stromal protein which is mostly secreted from cancer associated fibroblasts in the tumor microenvironment and can promote cancer progression including cell survival, metastasis, and chemoresistance. T...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Cancer
Main Authors: Oo, Khine Kyaw, Kamolhan, Thanpawee, Soni, Anish, Thongchot, Suyanee, Mitrpant, Chalermchai, O-charoenrat, Pornchai, Thuwajit, Chanitra, Thuwajit, Peti
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807878/
https://ncbi.nlm.nih.gov/pubmed/33446140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07761-w
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!